Regentatlantic Capital LLC Eli Lilly & CO Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Regentatlantic Capital LLC holds 27,940 shares of LLY stock, worth $24.8 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

27,940

Previous 31,898 12.41%

Holding current value

$24.8 Million

Previous $10.3 Million 12.65%

% of portfolio

0.27%

Previous 0.34%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.17 Million - $1.34 Million	-3,958 Reduced 12.41%	27,940 $9.03 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $307,996 - $361,633	1,105 Added 3.59%	31,898 $10.3 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $88,008 - $109,372	375 Added 1.23%	30,793 $8.82 Million
Q4 2021 Jan 27, 2022	BUY	$224.85 - $279.04 $174,483 - $216,535	776 Added 2.62%	30,418 $8.4 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.14 Million - $1.4 Million	5,124 Added 20.9%	29,642 $6.85 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $542,913 - $702,254	3,007 Added 13.98%	24,518 $5.63 Million
Q1 2021 Apr 29, 2021	BUY	$164.32 - $212.72 $1.57 Million - $2.03 Million	9,543 Added 79.74%	21,511 $4.02 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $84,799 - $112,209	650 Added 5.74%	11,968 $2.02 Million
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $69,015 - $79,829	472 Added 4.35%	11,318 $1.68 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $333,410 - $401,255	2,444 Added 29.09%	10,846 $1.78 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $60,001 - $74,264	-504 Reduced 5.66%	8,402 $1.17 Million
Q2 2019 Jul 23, 2019	BUY	$110.79 - $129.32 $609,345 - $711,260	5,500 Added 161.48%	8,906 $987,000
Q1 2019 May 03, 2019	BUY	$111.31 - $131.02 $28,495 - $33,541	256 Added 8.13%	3,406 $442,000
Q4 2018 Jan 30, 2019	BUY	$105.9 - $118.64 $2,223 - $2,491	21 Added 0.67%	3,150 $365,000
Q3 2018 Oct 30, 2018	BUY	$85.86 - $107.31 $27,475 - $34,339	320 Added 11.39%	3,129 $336,000
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $10,976 - $12,597	-145 Reduced 4.91%	2,809 $240,000
Q1 2018 Apr 23, 2018	SELL	$74.21 - $87.6 $23,005 - $27,156	-310 Reduced 9.5%	2,954 $229,000
Q4 2017 Jan 23, 2018	BUY	$81.94 - $87.89 $16,388 - $17,578	200 Added 6.53%	3,264 $276,000
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $236,142 - $262,094	3,064	3,064 $262,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Eli Lilly & CO Transaction History